Search

Displaying results 7411 - 7420 of 10000 in total
  1. Drug

    R3R01

    go.drugbank.com/drugs/DB18078
    Investigational

    R3R01 is an investigational lipid-modifying drug.

  2. Drug

    Garlic oil

    go.drugbank.com/drugs/DB15989
    Investigational

    Categories: Compounds used in a research, industrial, or household setting
  3. Drug

    Tadekinig alfa

    go.drugbank.com/drugs/DB14858
    Investigational

    Tadekinig alfa is under investigation in clinical trial NCT03113760 (Therapeutic Use of Tadekinig Alfa in NLRC4 Mutation and XIAP Deficiency).

  4. Drug

    Iomazenil

    go.drugbank.com/drugs/DB14971
    Investigational

    Iomazenil is under investigation in clinical trial NCT01590277 (Ability of Partial Inverse Agonist, Iomazenil, to Block Ethanol Effects in Humans).

  5. Drug

    TSHA-105

    go.drugbank.com/drugs/DB18328
    Investigational

    TSHA-105 is an adeno-associated virus serotype 9 (AAV9) vector with an engineered transgene encoding the human SLC13A5 protein.

  6. Drug

    SHR-A1904

    go.drugbank.com/drugs/DB18702
    Investigational

    SHR-A1904 is under investigation in clinical trial NCT04877717 (A Study of SHR-A1904 in Patients With Advanced Solid Cancer).

  7. Drug

    Cefetamet pivoxil

    go.drugbank.com/drugs/DB18915
    Investigational

    Cefetamet pivoxil is under investigation in clinical trial NCT04664803 (Safety and Efficacy of Cefecin Tab. in Patients With Acute Sinusitis).

    Synonyms: 5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-methyl-8-oxo-, (2,2-dimethyl-1-oxopropoxy)methyl ester, (6r-(6.alpha.,7.beta.(z)))-
  8. Drug

    Lacripep

    go.drugbank.com/drugs/DB18921
    Investigational

    Lacripep is under investigation in clinical trial NCT03226444 (Lacripep™ in Subjects With Dry Eye Associated With Primary Sjögren's Syndrome).

  9. Drug

    Tobevibart

    go.drugbank.com/drugs/DB18986
    Investigational

    Tobevibart is under investigation in clinical trial NCT05612581 (A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection).

  10. Drug

    AGI-134

    go.drugbank.com/drugs/DB19005
    Investigational

    AGI-134 is under investigation in clinical trial NCT03593226 (Study to Evaluate Safety & Tolerability of AGI-134 in Solid Tumour).